Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ)
CNY 20.19
(-0.39%)
CNY 20.19
(-0.39%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 813.01 Million CNY | -27.98% |
| 2022 | 1.12 Billion CNY | 239.53% |
| 2021 | 332.46 Million CNY | 18.14% |
| 2020 | 281.41 Million CNY | 28141168900.0% |
| 2019 | 1.00 CNY | -100.0% |
| 2018 | 200 Million CNY | 0.0% |
| 2017 | 200 Million CNY | 194.12% |
| 2016 | 68 Million CNY | 0.0% |
| 2015 | - CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| 2012 | - CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| 2010 | - CNY | 0.0% |
| 2009 | - CNY | 0.0% |
| 2008 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 781.57 Million CNY | -3.9% |
| 2024 Q2 | 550.15 Million CNY | -29.47% |
| 2024 Q3 | 764.91 Million CNY | 39.04% |
| 2023 Q4 | 813.01 Million CNY | -7.01% |
| 2023 Q3 | 874.27 Million CNY | -28.72% |
| 2023 FY | 813.01 Million CNY | -27.98% |
| 2023 Q2 | 1.22 Billion CNY | 16.85% |
| 2023 Q1 | 1.04 Billion CNY | -7.01% |
| 2022 Q3 | 634.52 Million CNY | 27.88% |
| 2022 Q2 | 496.18 Million CNY | 2.81% |
| 2022 FY | 1.12 Billion CNY | 239.53% |
| 2022 Q1 | 482.6 Million CNY | 45.16% |
| 2022 Q4 | 1.12 Billion CNY | 77.9% |
| 2021 Q1 | 281.39 Million CNY | -0.0% |
| 2021 FY | 332.46 Million CNY | 18.14% |
| 2021 Q2 | 147.17 Million CNY | -47.7% |
| 2021 Q4 | 332.46 Million CNY | 125.9% |
| 2021 Q3 | 147.17 Million CNY | -0.0% |
| 2020 FY | 281.41 Million CNY | 28141168900.0% |
| 2020 Q1 | 1.00 CNY | 0.0% |
| 2020 Q2 | 240 Million CNY | 23999999900.0% |
| 2020 Q3 | 280 Million CNY | 16.67% |
| 2020 Q4 | 281.41 Million CNY | 0.5% |
| 2019 Q1 | 200 Million CNY | 0.0% |
| 2019 FY | 1.00 CNY | -100.0% |
| 2019 Q2 | 200 Million CNY | 0.0% |
| 2019 Q3 | 200 Million CNY | 0.0% |
| 2019 Q4 | 1.00 CNY | -100.0% |
| 2018 Q2 | 200 Million CNY | 0.0% |
| 2018 FY | 200 Million CNY | 0.0% |
| 2018 Q4 | 200 Million CNY | 0.0% |
| 2018 Q3 | 200 Million CNY | 0.0% |
| 2018 Q1 | 200 Million CNY | 0.0% |
| 2017 Q4 | 200 Million CNY | 30.72% |
| 2017 FY | 200 Million CNY | 194.12% |
| 2017 Q3 | 153 Million CNY | 0.0% |
| 2017 Q2 | 153 Million CNY | -23.5% |
| 2017 Q1 | 200 Million CNY | 194.12% |
| 2016 Q4 | 68 Million CNY | 912680550400000000.0% |
| 2016 Q2 | 1.00 CNY | 0.0% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 FY | 68 Million CNY | 0.0% |
| 2016 Q3 | - CNY | -100.0% |
| 2015 Q3 | - CNY | 0.0% |
| 2015 Q2 | - CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 FY | - CNY | 0.0% |
| 2015 Q4 | - CNY | 0.0% |
| 2014 Q4 | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2014 Q2 | - CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 Q3 | - CNY | 0.0% |
| 2013 Q2 | - CNY | 0.0% |
| 2013 Q4 | - CNY | 0.0% |
| 2013 Q3 | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |
| 2013 Q1 | - CNY | 0.0% |
| 2012 Q1 | - CNY | 0.0% |
| 2012 FY | - CNY | 0.0% |
| 2012 Q2 | - CNY | 0.0% |
| 2012 Q3 | - CNY | 0.0% |
| 2012 Q4 | - CNY | 0.0% |
| 2011 Q3 | 50 Million CNY | 0.0% |
| 2011 Q2 | 50 Million CNY | 0.0% |
| 2011 Q4 | - CNY | -100.0% |
| 2011 FY | - CNY | 0.0% |
| 2010 FY | - CNY | 0.0% |
| 2010 Q4 | - CNY | 0.0% |
| 2009 FY | - CNY | 0.0% |
| 2008 FY | - CNY | 0.0% |